Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Goodrich

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|October 10, 2014
The Thoc1 ribonucleoprotein and prostate cancer progressionMeenalakshmi Chinnam, Yanqing Wang, Xiaojing Zhang, et al.
Cancers|May 28, 2022
Single-Cell Analyses of a Novel Mouse Urothelial Carcinoma Model Reveal a Role of Tumor-Associated Macrophages in Response to Anti-PD-1 TherapyDongbo Xu, Li Wang, Kyle Wieczorek, et al.
The Journal of Clinical Investigation|June 2, 2022
A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60Rahul Kumar, Ajay K Chaudhary, Jordan Woytash, et al.
Cancer Research|November 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease ProgressionJustine J Jacobi, Kristine M Wadosky, Neha Jaiswal, et al.
Oral Oncology|January 24, 2026
Prognostic associations of systemic inflammation response index (SIRI) in patients with head and neck cancer: a systematic review and meta-analysisNeil D Almeida, Tyler V Schrand, Daniel Sullivan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2006
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II studyAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
Molecular Cell|December 12, 2018
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 ExpressionXin Jin, Donglin Ding, Yuqian Yan, et al.
Cancer Research|August 8, 2025
Caloric Restriction Enhances the Efficacy of Anti-Androgen Therapy in Prostate Cancer by Inhibiting Androgen Receptor TranslationRicardo A Cordova, May Elbanna, Christopher Rupert, et al.
Science (New York, N.Y.)|January 7, 2017
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceSheng Yu Ku, Spencer Rosario, Yanqing Wang, et al.
Science Advances|April 8, 2021
Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancerSu H Park, Ka-Wing Fong, Jung Kim, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|October 10, 2014
The Thoc1 ribonucleoprotein and prostate cancer progressionMeenalakshmi Chinnam, Yanqing Wang, Xiaojing Zhang, et al.
Cancers|May 28, 2022
Single-Cell Analyses of a Novel Mouse Urothelial Carcinoma Model Reveal a Role of Tumor-Associated Macrophages in Response to Anti-PD-1 TherapyDongbo Xu, Li Wang, Kyle Wieczorek, et al.
The Journal of Clinical Investigation|June 2, 2022
A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60Rahul Kumar, Ajay K Chaudhary, Jordan Woytash, et al.
Cancer Research|November 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease ProgressionJustine J Jacobi, Kristine M Wadosky, Neha Jaiswal, et al.
Oral Oncology|January 24, 2026
Prognostic associations of systemic inflammation response index (SIRI) in patients with head and neck cancer: a systematic review and meta-analysisNeil D Almeida, Tyler V Schrand, Daniel Sullivan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2006
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II studyAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
Molecular Cell|December 12, 2018
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 ExpressionXin Jin, Donglin Ding, Yuqian Yan, et al.
Cancer Research|August 8, 2025
Caloric Restriction Enhances the Efficacy of Anti-Androgen Therapy in Prostate Cancer by Inhibiting Androgen Receptor TranslationRicardo A Cordova, May Elbanna, Christopher Rupert, et al.
Science (New York, N.Y.)|January 7, 2017
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceSheng Yu Ku, Spencer Rosario, Yanqing Wang, et al.
Science Advances|April 8, 2021
Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancerSu H Park, Ka-Wing Fong, Jung Kim, et al.
Pageof 8